DK157087D0 - Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus - Google Patents

Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus

Info

Publication number: DK157087D0
Authority: DK; Denmark
Prior art keywords: virus; vaccine; animals; wild; deletion
Prior art date: 1985-07-29

Application number

DK157087A

Other languages

English (en)

Other versions

DK170948B1 (da

DK157087A (da

Inventor

Leonard E Post

Darrell R Thomsen

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-29

Filing date

1987-03-27

Publication date

1987-03-27

1987-03-27 Application filed by Upjohn Co filed Critical Upjohn Co

1987-03-27 Publication of DK157087D0 publication Critical patent/DK157087D0/da

1987-03-27 Publication of DK157087A publication Critical patent/DK157087A/da

1996-03-25 Application granted granted Critical

1996-03-25 Publication of DK170948B1 publication Critical patent/DK170948B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Mycology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Plant Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Physics & Mathematics (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Oncology (AREA)

DK157087A 1985-07-29 1987-03-27 Ikke naturligt forekommende pseudorabiesvirus, vaccine indeholdende dette virus samt fremgangsmåde til serologisk skelnen mellem inficerede og vaccinerede dyr DK170948B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US76013085A	1985-07-29	1985-07-29
US76013085		1985-07-29
US8601322		1986-06-17
PCT/US1986/001322 WO1987000862A1 (en)	1985-07-29	1986-06-17	Virus vaccine

Publications (3)

Publication Number	Publication Date
DK157087D0 true DK157087D0 (da)	1987-03-27
DK157087A DK157087A (da)	1987-03-27
DK170948B1 DK170948B1 (da)	1996-03-25

Family

ID=25058182

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK157087A DK170948B1 (da)	1985-07-29	1987-03-27	Ikke naturligt forekommende pseudorabiesvirus, vaccine indeholdende dette virus samt fremgangsmåde til serologisk skelnen mellem inficerede og vaccinerede dyr

Country Status (18)

Country	Link
US (1)	US4810634A (da)
EP (1)	EP0231209B1 (da)
JP (2)	JP2559384B2 (da)
KR (1)	KR950000887B1 (da)
CN (1)	CN1018845B (da)
AT (1)	ATE60799T1 (da)
AU (1)	AU591145B2 (da)
CA (1)	CA1275625C (da)
DE (1)	DE3677494D1 (da)
DK (1)	DK170948B1 (da)
ES (1)	ES2001752A6 (da)
FI (1)	FI871362A7 (da)
HK (1)	HK32696A (da)
IE (1)	IE59087B1 (da)
NO (1)	NO301284B1 (da)
PH (1)	PH25776A (da)
WO (1)	WO1987000862A1 (da)
ZA (1)	ZA865277B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5041536A (en) *	1984-05-02	1991-08-20	The Upjohn Company	Pseudorabies virus (PRV) gene
US5128128A (en) *	1985-07-29	1992-07-07	The Upjohn Company	Virus vaccine
US5275934A (en) *	1985-07-29	1994-01-04	The Upjohn Company	Method of detecting viral infection in vaccinated animals
EP0263207B1 (en) *	1986-10-08	1991-11-27	The Upjohn Company	Virus vaccine
US5763269A (en) *	1985-09-06	1998-06-09	Syntro Corporation	Recombinant infectious bovine rhinotrocheitis virus
US5047237A (en) *	1985-09-06	1991-09-10	Prutech Research And Development Partnership	Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5068192A (en) *	1986-01-27	1991-11-26	Prutech Research And Development Partnership	Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
US5352575A (en) *	1985-10-04	1994-10-04	The Upjohn Company	Pseudorabies virus protein
WO1987002058A1 (en) *	1985-10-04	1987-04-09	The Upjohn Company	Pseudorabies virus protein
US5593873A (en) *	1986-01-27	1997-01-14	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus
EP0256092B1 (en) *	1986-01-27	1998-04-08	Syntro Corporation	Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
US6172186B1 (en)	1986-03-26	2001-01-09	Pharmacia & Upjohn Company	Pseudorabies virus protein
FR2601689B1 (fr) *	1986-07-17	1992-10-16	Syntro Corp	Herpes virus attenues, herpes virus qui renferment de l'adn etranger codant pour une sequence d'amino-acides, et vaccins les contenant
US5037742A (en) *	1986-07-18	1991-08-06	E. I. Du Pont De Nemours And Company	Pseudorabies virus recombinants and their use in the production of proteins
US5004693A (en) *	1986-07-18	1991-04-02	E. I. Du Pont De Nemours And Company	Pseudorabies virus recombinants and their use in the production of proteins
DE3853819T2 (de) *	1987-03-19	1995-09-21	Synergen Inc	Virales vektorsystem zum einführen fremder dns-expressionserzeugnisse in gallinaceenvögeln.
US5273876A (en) *	1987-06-26	1993-12-28	Syntro Corporation	Recombinant human cytomegalovirus containing foreign gene
US5783195A (en) *	1991-07-18	1998-07-21	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof
EP0332677B1 (en) *	1987-07-27	1995-07-19	Syntro Corporation	Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
US4992051A (en) *	1987-11-03	1991-02-12	Novagene, Inc.	Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same
US5128129A (en) *	1987-11-03	1992-07-07	Novagene Inc.	Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
US5069901A (en) *	1988-02-03	1991-12-03	Jones Elaine V	Preparation of a recombinant subunit vaccine against pseudorabies infection
JP2779447B2 (ja) *	1988-03-20	1998-07-23	財団法人阪大微生物病研究会	弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
JP2583115B2 (ja) *	1988-09-10	1997-02-19	財団法人化学及血清療法研究所	組換えマレック病ウイルスおよびその製法
US5122447A (en) *	1989-01-23	1992-06-16	Iowa State University Research Foundation, Inc.	Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen
US5240703A (en) *	1991-03-01	1993-08-31	Syntro Corporation	Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
CA2113641A1 (en) *	1991-07-18	1993-02-04	Mark D. Cochran	Recombinant infectious bovine rhinotracheitis virus
US5874279A (en) *	1991-07-18	1999-02-23	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus
WO1993024147A1 (en) *	1992-05-29	1993-12-09	Smithkline Beecham Corporation	Lecithin adjuvanted modified live virus vaccines
TW289731B (da) *	1992-07-09	1996-11-01	Akzo Nv
AU4702293A (en) *	1992-07-30	1994-03-03	Akzo Nobel N.V.	Vector vaccines of recombinant feline herpesvirus
US5738854A (en) *	1992-10-06	1998-04-14	Akzo Nobel N.V.	Pseudorabies virus vaccine
EP0619840A1 (en) *	1992-10-06	1994-10-19	Akzo Nobel N.V.	Pseudorabies virus vaccine
ES2074965B1 (es) *	1994-01-31	1996-05-01	Hipra Lab Sa	Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
JP3846808B2 (ja) *	1994-06-17	2006-11-15	インステイテユート・ボール・デイールホウデリイ・エン・デイールゲゾンドハイド	ペスチウイルス株のヌクレオチド配列、それらの配列によりコードされるポリペプチド、ならびにペスチウイルス感染の診断および予防のためのそれらの使用
US6284251B1 (en)	1996-02-26	2001-09-04	Kansas State University Research Foundation	BHV-1 gene-deleted virus vaccine
GB0126047D0 (en) *	2001-10-30	2001-12-19	Univ Cambridge Tech	Therapeutic molecules
US10918712B2 (en)	2014-03-03	2021-02-16	Albert Einstein College Of Medicine	Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
JP6652497B2 (ja) *	2014-03-03	2020-02-26	アルバートアインシュタインカレッジオブメディシン	組換え単純ヘルペスウィルス２（ｈｓｖ−２）ワクチンベクター
WO2017106736A1 (en) *	2015-12-18	2017-06-22	Louisiana State University Research & Technology Foundation	Pseudorabies virus (prv) vector expressing heterologous polypeptides
PH12021551028A1 (en) *	2018-11-06	2022-10-03	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic composition against avian influenza virus h5 subtype

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4603112A (en) *	1981-12-24	1986-07-29	Health Research, Incorporated	Modified vaccinia virus
NL8303501A (nl) *	1983-10-12	1985-05-01	Centraal Diergeneeskundig Inst	Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
US4514497B1 (en) *	1983-12-30	1998-02-24	Novagene Inc	Modified live pseudorabies viruses
US4703011A (en) *	1985-11-12	1987-10-27	Novagene, Inc.	Thymidine kinase deletion mutants of bovine herpesvirus-1
US4711850A (en) *	1986-01-28	1987-12-08	Novagene, Inc.	Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same

1986
- 1986-06-17 AT AT86904022T patent/ATE60799T1/de not_active IP Right Cessation
- 1986-06-17 AU AU59948/86A patent/AU591145B2/en not_active Expired
- 1986-06-17 EP EP86904022A patent/EP0231209B1/en not_active Expired - Lifetime
- 1986-06-17 JP JP61503474A patent/JP2559384B2/ja not_active Expired - Lifetime
- 1986-06-17 FI FI871362A patent/FI871362A7/fi not_active Application Discontinuation
- 1986-06-17 DE DE8686904022T patent/DE3677494D1/de not_active Expired - Lifetime
- 1986-06-17 WO PCT/US1986/001322 patent/WO1987000862A1/en not_active Ceased
- 1986-06-17 KR KR1019870700280A patent/KR950000887B1/ko not_active Expired - Lifetime
- 1986-06-17 US US07/049,865 patent/US4810634A/en not_active Expired - Lifetime
- 1986-07-11 CA CA000513617A patent/CA1275625C/en not_active Expired - Lifetime
- 1986-07-15 ZA ZA865277A patent/ZA865277B/xx unknown
- 1986-07-23 PH PH34058A patent/PH25776A/en unknown
- 1986-07-28 IE IE199686A patent/IE59087B1/en not_active IP Right Cessation
- 1986-07-28 ES ES8600629A patent/ES2001752A6/es not_active Expired
- 1986-07-29 CN CN86105450A patent/CN1018845B/zh not_active Expired
1987
- 1987-03-27 NO NO871313A patent/NO301284B1/no not_active IP Right Cessation
- 1987-03-27 DK DK157087A patent/DK170948B1/da active IP Right Grant
1995
- 1995-12-18 JP JP7328734A patent/JP2738524B2/ja not_active Expired - Lifetime
1996
- 1996-02-22 HK HK32696A patent/HK32696A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1018845B (zh)	1992-10-28
CA1275625C (en)	1990-10-30
AU5994886A (en)	1987-03-05
KR880700070A (ko)	1988-02-15
FI871362A0 (fi)	1987-03-27
DK170948B1 (da)	1996-03-25
NO871313D0 (no)	1987-03-27
JPH08333279A (ja)	1996-12-17
NO301284B1 (no)	1997-10-06
EP0231209B1 (en)	1991-02-06
IE59087B1 (en)	1994-01-12
DE3677494D1 (de)	1991-03-14
IE861996L (en)	1987-01-29
DK157087A (da)	1987-03-27
EP0231209A1 (en)	1987-08-12
ZA865277B (en)	1987-03-25
JP2559384B2 (ja)	1996-12-04
JP2738524B2 (ja)	1998-04-08
FI871362L (fi)	1987-03-27
PH25776A (en)	1991-10-18
ATE60799T1 (de)	1991-02-15
US4810634A (en)	1989-03-07
NO871313L (no)	1987-03-27
AU591145B2 (en)	1989-11-30
FI871362A7 (fi)	1987-03-27
KR950000887B1 (ko)	1995-02-03
HK32696A (en)	1996-03-01
WO1987000862A1 (en)	1987-02-12
ES2001752A6 (es)	1988-06-16
JPS63500449A (ja)	1988-02-18
CN86105450A (zh)	1987-03-04

Publication	Publication Date	Title
DK157087D0 (da)	1987-03-27	Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
DE69206631D1 (de)	1996-01-18	Impfstoff gegen das Fortpflanzungs- und Atmungssyndrom bei Schweinen (PRRS) und Diagnose.
UA40571C2 (uk)	2001-08-15	Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
Woode et al.	1987	Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses
EP0232798A3 (en)	1987-10-14	Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
BR0012433A (pt)	2002-05-21	Vìrus recombinante, infeccioso de doença bursal infecciosa, método para obter o mesmo, ibdv mosaico infeccioso (mibdv), e, vacina
ATE102650T1 (de)	1994-03-15	Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
van Rooij et al.	2002	Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant
DE69332264D1 (de)	2002-10-10	Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
ATE285791T1 (de)	2005-01-15	Impfstoff, der acemannan als adjuvans enthält
CA2012414A1 (en)	1990-09-19	Hog cholera virus vaccine and diagnostic
ES2053477T3 (es)	1994-08-01	Vacuna viva para enfermedades contagiosas de pollos.
DE69203950D1 (de)	1995-09-14	Rekombinanter Impfstoff gegen Marek's Krankheit.
DE122007000004I1 (de)	2007-05-24	Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe
EP0496787A4 (en)	1993-04-28	Novel infectious bursal disease virus
Joklik	1984	Antigenic relationships between the proteins of the three serotypes of reovirus.
Joncas et al.	1977	Burkitt's lymphoma of the jaw in a Canadian child
Babiker	1999	Immune responses to a live virus vaccine candidate and protection against pseudorabies virus infection
ES2105984A1 (es)	1997-10-16	Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
ES2074965A1 (es)	1995-09-16	Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Dory et al.	2007	Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination

Legal Events

Date	Code	Title	Description
1996-03-25	B1	Patent granted (law 1993)